Clinical Trials
2 trialsNCT02444793 2019-02-27
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT02179918 2019-02-08
A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)
Pfizer
Phase 1 Completed